http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25580653

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Intramural|Research Support, Non-U.S. Gov't
endingPage 204
issn 1538-067X
1092-1095
issueIdentifier 2
pageRange 195-204
publicationName Clinical Journal of Oncology Nursing
startingPage 195
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2c3e2e437a6b312979c7de4a1f5faa45
bibliographicCitation Frye R, Myers M, Axelrod KC, Ness EA, Piekarz RL, Bates SE, Booher S. Romidepsin: A New Drug for the Treatment of Cutaneous T-Cell Lymphoma. Clinical Journal of Oncology Nursing. 2012 Mar 29;16(2):195–204. doi: 10.1188/12.cjon.195-204.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f30e216964fe12f907d67c89498a776
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99ab6d3bbe98b6d9eac5ace739ebcb2b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cef9ba4f1260f0435eca4fb7faa09c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90b491f82694bd541c80f82fdd85ca85
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be6b2b383b66deb6876ccb70d41b63af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bec23c59066ca7a9b9e283f46c0db7c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645be7ac294f9da536395b2e8d785268
date 2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1188/12.cjon.195-204
https://pubmed.ncbi.nlm.nih.gov/22459529
https://pubmed.ncbi.nlm.nih.gov/PMC7243910
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20775
https://portal.issn.org/resource/ISSN/1092-1095
https://portal.issn.org/resource/ISSN/1538-067X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Romidepsin: A New Drug for the Treatment of Cutaneous T-Cell Lymphoma
discusses http://id.nlm.nih.gov/mesh/M0519758
http://id.nlm.nih.gov/mesh/M0458175
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0527853
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D047630Q000627
http://id.nlm.nih.gov/mesh/D012878Q000188
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D016399Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016399Q000451
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012008
http://id.nlm.nih.gov/mesh/D047630Q000009
http://id.nlm.nih.gov/mesh/D012878Q000451
http://id.nlm.nih.gov/mesh/D056572Q000627
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D000970Q000009
http://id.nlm.nih.gov/mesh/D002986
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352062
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9860
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248745162

Total number of triples: 52.